Immunotherapy with Sensitized Lymphocytes
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 10 (5) , 357-369
- https://doi.org/10.3109/07357909209024795
Abstract
(1992). Immunotherapy with Sensitized Lymphocytes. Cancer Investigation: Vol. 10, No. 5, pp. 357-369. doi: 10.3109/07357909209024795Keywords
This publication has 39 references indexed in Scilit:
- Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyCellular Immunology, 1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2Annals of Surgery, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.The Journal of Experimental Medicine, 1981
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976